Urgently revise Tamiflu and Relenza recommendations, warns Cochrane review
This article was originally published in Scrip
Executive Summary
There is no evidence to support the use of antivirals Tamiflu (oseltamivir) and Relenza (zanamivir) to prevent serious outcomes in flu outbreaks, and little support for stockpiling the drugs in case of an epidemic, says a damning report by the Cochrane Collaboration published 10 April.